The use of autologous LMP2-specific cytotoxic T lymphocytes for the treatment of relapsed EBV+ Hodgkin’s disease and non-Hodgkin’s lymphoma

Saved in:
Bibliographic Details
Published inBiology of blood and marrow transplantation Vol. 11; no. 2; p. 18
Main Authors Bollard, C.M., Straathof, K.C., Huls, H., Gresik, V., Carrum, G., Gottschalk, S., Gee, A., Brenner, M.K., Rooney, C.M., Heslop, H.E.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.02.2005
Online AccessGet full text

Cover

More Information
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2004.12.052